|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
00954 CHANGMAO BIO
Nominal 
0.350 0.000 (0.000%) | 2025/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | |
| Turnover | 556,925 | -4.766% | 584,794 | 637,078 | 730,034 | 547,976 |
| Cost of Sales | (539,092) | -5.092% | (568,017) | (611,269) | (549,203) | (509,296) |
| Gross Profit | 17,833 | 6.294% | 16,777 | 25,809 | 180,831 | 38,680 |
| 2025/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | 41 | -- | (205) | (183) | 136 | (28) | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | 0 | -- | 0 | 0 | 0 | 0 | |
| Profit / (Loss) before Taxation | (64,963) | -3.875% | (67,582) | (58,580) | 87,644 | 84,409 | |
| Taxation | (2,207) | 229.895% | (669) | (27,938) | (6,286) | (26,202) | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | 407 | 4987.500% | 8 | 461 | 65 | 111 | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | (66,763) | -2.169% | (68,243) | (86,057) | 81,423 | 58,318 | |
| 2025/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | |
| Net Finance Costs / (Income) | 16,593 | 57.818% | 10,514 | 6,532 | 1,729 | 1,415 |
| Depreciation & Amortisation | 52,936 | 16.047% | 45,616 | 42,745 | 32,202 | 29,214 |
| Directors' Emoluments | -- | -- | 1,987 | 1,979 | 6,615 | 1,831 |
| 2025/12 - Final | %Chg (Compare to Final) | 2024/12 | 2023/12 | 2022/12 | 2021/12 | |
| Auditor's Opinion Status | Unqualified (Modified Report) | -- | Unqualified (Modified Report) | Unqualified | Unqualified | Unqualified |
Market Valuation Indicators
| 2025/12 - Final | %Chg (Compare to Final) | 2024/12 | 2023/12 | 2022/12 | 2021/12 | |
| EPS (cts) | -12.600 | -2.326% | -12.900 | -16.200 | 15.400 | 11.000 |
| DPS (cts) | 0.000 | -- | 0.000 | 0.000 | 7.700 | 0.000 |
| Dividend Payout Ratio (%) | -- | -- | -- | -- | 50.000% | -- |
| Cash flow per share ($) | -- | -- | (0.061) | (0.004) | 0.037 | (0.013) |
| NBV per share ($) | 0.975 | -- | 1.101 | 1.230 | 1.470 | 1.316 |
| Remarks: | Real time quote last updated: 01/04/2026 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB -66,763 |
| %Change | -2.169% |
| EPS / (LPS) | RMB -0.126 |
| NBV Per Share (¥) | RMB 0.975 |